Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Safety & Efficacy of Peginesatide for Maintenance Treatment of Anemia in Participants With Chronic Kidney Disease on Hemodialysis

ClinicalTrials.gov ID: NCT00597584

Public ClinicalTrials.gov record NCT00597584. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 28, 2026, 3:44 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

AFX01-14: A Phase 3, Randomized, Active-controlled, Open-label, Multi-center Study of the Safety and Efficacy of Peginesatide for the Maintenance Treatment of Anemia in Hemodialysis Patients Previously Treated With Epoetin

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study was to evaluate the safety and efficacy of peginesatide in the maintenance treatment of anemia in participants on dialysis.

Study identification

NCT ID
NCT00597584
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Affymax
Industry
Enrollment
823 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 2007 (Type not available)
Primary completion
Jul 2009 (Actual)
Completion
Jan 2010 (Actual)
Last update posted
Mar 8, 2013

2007 – 2010

United States locations

U.S. sites
39
U.S. states
20
U.S. cities
36
Facility City State ZIP Site status
Research Facility Phoenix Arizona 85012 —
Research Facility Hot Springs Arkansas 71901 —
Research Facility McGehee Arkansas 71654 —
Research Facility Pine Bluff Arkansas 71603 —
Research Facility Bakersfield California 93309 —
Research Facility Glendale California 91205 —
Research Facility Los Angeles California 90033 —
Research Facility Los Angeles California 90048 —
Research Facility Los Angeles California 90073 —
Research Facility Riverside California 92505 —
Research Facility Simi Valley California 93065 —
Research Facility Whittier California 90602 —
Research Facility Yuba City California 95991 —
Research Facility Westminster Colorado 80031 —
Research Facility Lauderdale Lakes Florida 33313 —
Research Facility Miami Florida 33173 —
Research Facility Pinecrest Florida 33156 —
Research Facility Flossmoor Illinois 60422 —
Research Facility Hines Illinois 60141 —
Research Facility Louisville Kentucky 40202 —
Research Facility Rockville Maryland 20850 —
Research Facility Springfield Massachusetts 01107 —
Research Facility Detroit Michigan 48202 —
Research Facility Detroit Michigan 48236 —
Research Facility Brookhaven Mississippi 39601 —
Research Facility Brooklyn New York 11238 —
Research Facility Flushing New York 11355 —
Research Facility The Bronx New York 10461 —
Research Facility Asheville North Carolina 28801 —
Research Facility Toledo Ohio 43606 —
Research Facility Oklahoma City Oklahoma 73116 —
Research Facility Erie Pennsylvania 16507 —
Research Facility Philadelphia Pennsylvania 19141 —
Research Facility Providence Rhode Island 02904 —
Research Facility Orangeburg South Carolina 29118 —
Research Facility Arlington Texas 76015 —
Research Facility Houston Texas 77099 —
Research Facility San Antonio Texas 78215 —
Research Facility Fairfax Virginia 22033 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 45 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00597584, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 8, 2013 · Synced Oct 28, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00597584 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →